Technical Articles
drug development
Why Three Drug-Development Routes All Validate Through IL-12 R beta 1: From p40 and p19 to the Receptor Side
p40 blockers, p19-selective IL-23 inhibitors and receptor-side programs all converge on IL-12Rβ1 engagement assays. This article traces the validation chain.
View details
- Immunity/Inflamma
- IL-12 R beta 1
- IL-23
- p40
- p19
- drug development
- target validation
- UA010373
IL-2/IL-2R Signaling Pathway: Dual Regulation of Immune Balance and Targeted Drug Development
Interleukin-2 is a cytokine that plays a central role in immune regulation. The realization of its biological effects depends on precise binding with the cell surface interleukin-2 receptor.
View details
- Immunity/Inflamma
- IL2/IL2R Kit
- Immune balance
- Drug development
Unveiling the Dynamic Code of Life: pH-sensitive IgG IgG Labeling Reagents Max(Green)
In the traditional fields of life sciences and drug development, the vast majority of cellular experiments are conducted in two-dimensional culture dishes. However, this monolayer cell model differs significantly from the complex three-dimensional microenvironment in which cells reside within the human body, leading to a substantial gap between experimental data and actual in vivo responses. To bridge this divide, 3D cell viability assay technology has emerged, becoming a powerful tool for revolutionizing disease research, drug screening, and toxicology assessment.
View details
- Cancer
- Cell Viability Assay
- Drug Development
- 1








